MedPath

Investigation of the Effect of Acceptance and Commitment Therapy-Based Intervention in Oncology Patients

Not Applicable
Not yet recruiting
Conditions
Acceptance and Commitment Therapy
Interventions
Behavioral: Psychoeducation for Oncology Patients
Behavioral: Acceptance and Commitment Therapy-Based Intervention for Oncology Patients
Registration Number
NCT06457178
Lead Sponsor
Istanbul University - Cerrahpasa
Brief Summary

The goal of this clinical trial is to investigate the effectiveness of Acceptance and Commitment Therapy Based Intervention for Oncology Patients. The main questions it aims to answer are:

* Does the Acceptance and Commitment to Therapy-Based Intervention for Oncology Patients affect the level of psychological distress?

* Does the Acceptance and Commitment to Therapy-Based Intervention for Oncology Patients affect the level of reintegration into normal life?

Researchers will compare Acceptance and Commitment Therapy-Based Intervention for Oncology Patients (ACT) to Psychoeducation for Oncology Patients and routine care (with no specific intervention) to see if Acceptance and Commitment Therapy-Based Intervention for Oncology Patients is effective in psychological distress and reintegration into normal living.

Detailed Description

Participants:

* They will be randomly divided into three groups (Group 1: ACT, Group 2: Psychoeducation, Group 3: Routine care).

* All participants will be asked to complete data collection forms.

* Group 1 will participate in a 5-session Acceptance and Commitment Therapy-Based Intervention for Oncology Patients intervention program.

* Group 2 will participate in a 5-session Psychoeducation for Oncology Patients program.

* During this period, participants in group 3 will continue their routine treatment.

* After completion of the interventions, participants will be asked to complete the data collection forms again.

* The researchers will then analyze the results and write the report.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
75
Inclusion Criteria
  • 18 years of age or older,
  • Being able to read and write,
  • Receiving oncologic treatment,
  • Being diagnosed with breast cancer,
  • To know about Medical Diagnosis,
  • Being in stage 1, 2 or 3 of the disease,
  • Receiving outpatient chemotherapy treatment only,
  • Internet access and computer skills to participate in online group interviews,
  • Low to moderate scores on the brief psychological resilience scale,
Exclusion Criteria
  • Having serious psychiatric or cognitive impairments that limit adherence to group sessions,
  • Having a physical disability that may make it difficult to participate in group sessions,
  • Failure to attend sessions regularly and absenteeism,
  • Currently being in a psychoeducation/psychotherapy group

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Psychoeducation for Oncology PatientsPsychoeducation for Oncology PatientsGroup 2 will participate in a 5-session Psychoeducation for Oncology Patients program.
Acceptance and Commitment Therapy Based Intervention for Oncology PatientsAcceptance and Commitment Therapy-Based Intervention for Oncology PatientsGroup 1 will participate in a 5-session Acceptance and Commitment Therapy-Based Intervention for Oncology Patients intervention program.
Primary Outcome Measures
NameTimeMethod
The Distress Thermometer (DT)one month after the end of the interventions

The scale was developed to measure psychological distress in cancer patients. The problems in the list are grouped into five areas. These are daily life problems, family problems, emotional problems, faith-related problems, and physical problems. The patient marks which one or which areas of the list he/she has experienced problems in the last week. The cut-off point of the scale in our country was found to be 4. The National Comprehensive Cancer Network (NCCN) argues that patients who score 5 or above on the distress thermometer are in significant distress and should be supported by professionals.

Secondary Outcome Measures
NameTimeMethod
Reintegration to Normal Living Index (RNLI)one month after the end of the interventions

The Reintegration to Normal Living Index (RNLI) has two sub-dimensions. These are: daily functions and self-perceptions. The scale is scored on a five-point Likert scale: Strongly Disagree (1 point), Disagree (2 points), Undecided (3 points), Agree (4 points) and Strongly Agree (5 points). Scores that can be obtained from the scale vary between 11 and 55. A high score on the scale indicates a better level of participation in normal life.

© Copyright 2025. All Rights Reserved by MedPath